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AbstrAct 
Objective To compare the risk of lower extremity 
amputation (LEA) in people with diabetes with and without 
comorbid depression.
Research design and methods A systematic review of 
the published literature was conducted. Six databases 
were searched including PubMed, CINAHL, EMBASE, 
Medline, the Cochrane Library and PsycARTICLES from 
inception to 22 June 2016, using a detailed search 
strategy and cross-checking of reference lists for 
potentially eligible studies published in English. No date 
restrictions were employed. All studies were reviewed 
independently for inclusion by two review authors. 
Data extraction was performed using a standardized 
data abstraction form, and study quality was assessed 
independently by two reviewers. A meta-analysis was 
performed reporting pooled hazard ratios (HRs) and 95% 
CIs in Review Manager software.
Results In total, seven studies were eligible for inclusion 
in the systematic review. Data on 767 997 patients from 
five studies were included in the meta-analysis. Pooled 
estimates across the studies were obtained using a 
random-effects model due to significant heterogeneity 
(I2=87%). People with diabetes and depression had an 
increased hazard of LEA (HR 1.76, 95% CI 1.19 to 2.60) 
compared to people with diabetes and no depression.
Conclusions Based on the available evidence, comorbid 
depression appears to increase the risk of LEA in people 
with diabetes. Limited data were available, however, 
with significant heterogeneity between studies. Further 
research is needed to inform intervention and clinical 
practice development in the management of diabetes.
IntROduCtIOn
depression and diabetes
The presence of diabetes doubles the odds of 
comorbid depression.1 In the USA, the 2006 
Behavioral Risk Factor Surveillance System 
documented that depression was highly prev-
alent among people with diabetes and that the 
prevalence rate varied greatly by demographic 
characteristics and diabetes types.2 The Diabetes 
Attitudes, Wishes and Needs study (DAWN2) 
assessed psychosocial outcomes in people with 
diabetes across 17 countries and documented 
that the proportion with likely depression 
(WHO-5 Well-Being Index score ≤28) was 
13.8% (country range 6.5%–24.1%).3
The etiology of the relationship between 
depression and diabetes is multifactorial.4 Risk 
factors for the development of depression 
among people with diabetes include gender, 
age, years since diagnosis, socioeconomic 
status, HbA1c control (HbA1c refers to glycated 
haemoglobin (A1c), which identifies average 
plasma glucose concentration), number of 
complications, insulin dose, number of injec-
tions, ketoacidosis admission and living alone.5
depression, diabetes and lower extremity 
amputations
When diabetes and depression coexist, 
depression is negatively associated with adher-
ence to diabetes management including 
self-care of diet, medication, exercise, blood 
glucose monitoring and medical appoint-
ment attendance.6 This increases the risk of 
complications in people with diabetes.
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significance of the study
What is already known about this subject?
 ► People with diabetes are at increased risk of lower 
extremity amputation (LEA). As the prevalence of 
diabetes escalates worldwide, it is anticipated that 
there will be an increase in the number of LEAs. The 
effect of comorbid depression on the risk of LEA in 
people with diabetes is unclear.
What are the new findings?
 ► Very limited data are available. Based on the 
available evidence, however, there appears to be an 
unfavorable effect of comorbid depression on the 
risk of LEA in people with diabetes.
How might these results change the focus of 
research or clinical practice?
 ► Further research on the effect of comorbid 
depression on the risk of developing the long-term 
outcome of LEA in people with diabetes is warranted.
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LEA is one complication of diabetes, is multifactorial7 and 
negatively impacts on a patient’s quality of life.8 Diabetes is 
associated with a significantly increased risk of LEA.9 LEA 
rates vary between populations with estimates ranging from 
46 to 9600/105 people with diabetes.10 The International 
Diabetes Federation (IDF) and the International Working 
Group on the Diabetic Foot have prioritised reducing LEA 
rates in people with diabetes.11
Little is documented on the role of comorbid depression 
on LEA rates in people with diabetes. The relationship 
between depression and foot complications in people with 
diabetes is likely to be bi-directional.12 Previous research 
has suggested that comorbid depression is associated with 
risk factors for the development of diabetes-related compli-
cations. A retrospective cohort study showed a 33% higher 
risk of major LEA in veterans with diabetes and comorbid 
depression.13 Also, in a veteran population, a five-point 
increase in mental health functioning score was associated 
with a 5% decrease in risk of major LEAs (OR 0.95, 95% CI 
0.94 to 0.96) after controlling for independent variables14.
Rationale for the current systematic review and meta-
analysis
LEA is a concrete and easily definable outcome that is 
more common in people with diabetes.10 Significant 
reductions in the incidence of LEA have been shown 
with various interventions that target risk factors in 
people with diabetes.10 15 The role of comorbid depres-
sion as a risk factor for LEA in people with diabetes is 
uncertain. Given that there are a number of successful 
treatments available for depression, it could be a modi-
fiable risk factor for the development of LEA in people 
with diabetes. Thus, the aim of this systematic review was 
to identify all of the published literature to date and to 
provide an overall quantitative estimate of the relation-
ship using a meta-analysis.
ReseaRCH desIgn and metHOds
Primary objective
The primary objective of this systematic review was to 
synthesize the available published literature to date on 
the relationship between depression among people with 
diabetes and the risk of LEA.
The secondary objective was to quantify the findings 
from each included study and to report an overall pooled 
estimate of the relationship between depression and risk 
of LEA in the form of a meta-analysis.
Primary outcome
The outcome of interest in this review was LEA in people 
with diabetes and depression compared to people with 
diabetes and no depression. This outcome was used in 
the meta-analysis to estimate the pooled risk of LEA 
among people with diabetes and depression.
exposure
Depression defined by self-report, clinical diagnosis or a 
combination of both.
search strategy
The protocol for this systematic review and meta-analysis 
was registered on PROSPERO, the international prospec-
tive register of systematic reviews (unique identification 
number: CRD42014013897), and is available in full on 
the National Institute for Health Research website.16 This 
systematic review and meta-analysis was conducted in 
accordance with the preferred reporting items for system-
atic reviews and meta-analyses statement (PRISMA),17 
which is a detailed checklist of items specifically designed 
for this purpose. The following databases were searched 
from inception until 22 June 2016: PubMed, CINAHL, 
EMBASE, Medline, the Cochrane Database of System-
atic Reviews and PsycARTICLES. The key search terms 
used included ‘diabetes’, ‘amputation’ and ‘depres-
sion’ (online supplementary table 1). MeSH (Medical 
Subject Heading) terms and truncation as appropriate 
according to the principles of Boolean logic were used 
(eg, diabet* was used to include studies referring to 
diabetes, diabetic, etc). There were no date restrictions 
applied; however, only published studies in the English 
language were considered for review. We supplemented 
our electronic searches by cross-checking the reference 
lists of all included studies.
study selection
Titles, abstracts and full texts of potentially eligible 
studies were assessed by two reviewers (SON and CMB) 
for inclusion using a priori defined inclusion exclusion 
criteria (online supplementary table 2). Where the 
reviewers could not agree on study eligibility, consensus 
was reached by asking a third reviewer (ZK). Regarding 
multiple reports from the same dataset, only one report 
was included in the systematic review and meta-analysis 
based on the primary outcome of the study, sample size 
and length of follow-up.
Eligibility criteria for inclusion in the meta-analysis 
included
 ► Data were from an original study (ie, no review 
articles, editorials or commentaries).
 ► Randomized and non-randomized studies in which 
depression was measured at baseline and LEA was 
an outcome measure after a period of follow-up.
 ► Reporting of an adjusted relative risk (RR), OR, HR 
or incidence rate ratio on the measured exposure of 
depression and the outcome of LEA.
 ► Where only crude estimates (ie, potential 
confounders were not taken into account in the 
analysis) are presented in a study, these studies 
will not be included in the meta-analysis, and their 
results will be presented individually in a separate 
table.
data abstraction
Data on eligible studies were summarized systematically 
by two reviewers (SON, CMB) using a standardised data 
abstraction form and included author and year of publi-
cation, the country the study was conducted in and time 
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Table 1 Characteristics of studies included in the systematic review
Study authors 
(year)
Country (time 
period)
Study design 
(data source) Sample size
Depression 
diagnosis
Outcome diagnosis 
amputation
Black et al 
(2003)23
USA (baseline 
interview 1993–
1994; follow-up 
waves in 1995–
1996, 1998–1999, 
2000–2001)
Prospective 
cohort 
(longitudinal 
data from the 
EPESE survey)
3050 community-
dwelling Mexican 
Americans 
aged ≥65 years with 
type 2 diabetes
CESD scale 
(validated) and 
CIDI criteria 
(validated)
Self-reported in interview, 
grouped ‘microvascular 
complications’ outcome 
(amputation, nephropathy, 
retinopathy, neuropathy)
Gendelman et al 
(2009)24
USA (2006–2008) Cross-sectional 
(data from the 
CACTI study)
1004 participants 
(n=458 type 1 
diabetics)
BDI-II scale 
(validated) and/or 
self-reported use 
of antidepressant 
medication
Self-reported in interview
Lin et al (2010)25 USA (baseline 
survey 2000–2002; 
follow-up telephone 
call 2005–2007)
Prospective 
cohort (data 
from the PEFS 
study)
4623 participants 
with type 2 
diabetes (3723 
included in 
analysis)
PHQ-9 self-
reported 
questionnaire 
(validated)
Medical record review 
using ICD-9 codes, 
physician diagnosed. 
Grouped ‘microvascular 
outcome’ (amputation, end-
stage renal disease, eye 
complications, foot ulcers)
Pearson et al 
(2014)26
Australia (February–
August 2012)
Cross-sectional 
survey of 
patients 
attending 
podiatry clinic
60 patients with 
type 1 or 2 diabetes
PHQ-9 self-
reported 
questionnaire 
(validated)
Medical record review
Salmi et al 
(2011)27
Sweden (2006), 
follow-up 2007–
2009
National 
register-based 
cohort
229 956 patients 
prescribed 
antidiabetic drugs
Not reported 
(abstract only) but 
most likely ICD 
codes
Not reported (abstract only) 
but most likely ICD codes
Williams et al 
(2011)13
USA (2000), follow-
up until 2004
Prospective 
cohort (Diabetes 
Epidemiology 
Registry)
531 973 veterans 
with diabetes (type 
unknown)
ICD-9 codes ICD-9 codes
Winkley et al 
(2007)28
UK (2001–2003), 
follow-up 
18 months
Prospective 
cohort
253 type 1 or 2 
diabetic patients 
attending a 
podiatry clinic
SCAN 2.1 
diagnostic 
interview
Recorded by trained 
podiatrist
BDI-II, Beck Depression Inventory—version two; CACTI, Coronary Artery Calcification in Type I Diabetes Study; CESD, Center for 
Epidemiologic Studies Depression Scale; CIDI, Composite International Diagnostic Interview; EPESE, Established Population for the 
Epidemiologic Study of the Elderly Survey; ICD, International Classification of Diseases; PEFS, Pathways Epidemiologic Follow-Up Study; 
PHQ-9, Patient Health Questionnaire version 9; SCAN, Schedules for Clinical Assessment in Neuropsychiatry.
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period, study design, data source, sample size, diagnosis 
of the exposure and outcome (table 1). Where data 
required for the review were missing, the authors were 
contacted.
data synthesis and meta-analysis
Our principal analysis investigated the overall risk of LEA 
in people with diabetes and depression compared to 
people with diabetes and no depression. Pooled estimates 
across studies were obtained by means of a random-effects 
model where heterogeneity was considered substan-
tial (ie, an I2 value of greater than 50%) based on the 
Cochrane criteria.18 Studies were weighted according to 
an estimate of statistical size defined as the inverse of the 
variance (IV) of the HR.19 Where data were presented 
in a way that could not be included in a meta-analysis, 
results of the studies are presented individually in a table. 
Statistical analysis was performed using the Cochrane 
Collaboration’s Review Manager V.5.1 software.20
A priori subgroup analyses
The review team decided on the following a priori defined 
subgroup analyses: by type of diabetes (type 1 vs type 2), 
by study design, by sample size (<10 000 vs >10 000), by 
country in which the study was conducted and by study 
quality (risk of bias minimal, low, moderate or high).
Heterogeneity assessment
The degree of variability between studies attributable to 
between-study heterogeneity was assessed using the χ2 
heterogeneity test and the I2 statistic. In the χ2 test, a p 
value lower than 0.05 indicates statistical heterogeneity.21 
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When interpreting the I2 statistic, heterogeneity was 
measured according to the Cochrane Handbook guide-
lines with 0%–40% suggesting heterogeneity might 
not be important, 30%–60% may represent moderate 
heterogeneity, 50%–90% to be considered substan-
tial heterogeneity and 75%–100% being considerable 
heterogeneity.21
Quality assessment
Quality assessment of the studies included in the review 
was conducted independently by two reviewers (SON, 
CMB) using the six types of bias tool described in detail 
in a previous study.22 Studies were assessed based on the 
perceived amount of each bias present (selection, expo-
sure, outcome, confounding, analytical and attrition) and 
rated as minimal, low, moderate, high or not reported. 
An overall likelihood of bias was then estimated. The 
bias assessment tool is available in  online supplementary 
table 3.
Results
The initial electronic database searches yielded 384 
studies with 74 duplicates to result in 310 studies eligible 
for screening. Of these, 279 were rejected based on 
reading the abstracts and application of the inclusion 
criteria. The full texts of 31 studies were retrieved and 
reviewed for inclusion or exclusion (figure 1). Studies 
were excluded based on population, exposure, compar-
ison or outcome. Multiple studies from the same dataset 
were excluded if the dataset was already deemed included 
in another study. Studies measuring the exposure of 
depression after LEA or not relating to baseline were 
excluded. Studies not measuring the impact of depres-
sion at baseline and the outcome of LEA after a period 
of follow-up were excluded (n=24). In total, seven studies 
met the inclusion criteria for the systematic review,13 23–28 
of which five studies provided data for the meta-anal-
ysis.13 23 25 27 28
Characteristics of studies included in the systematic review
Characteristics of studies included in the systematic 
review are presented in table 1.
All of the studies were conducted in the 21st century 
(one in 2003,23 one in 2007,28 one in 2009,24 one in 
2010,25 two in 201113 27 and one in 201426). Four were 
conducted in the USA,13 23–25 one in Australia,26 one in 
Sweden27 and one in the UK.28 Five of the studies were 
prospective cohorts13 23 25 27 28 and two had a cross-sec-
tional study design.24 26 The sample size ranged from 
60 people26 to 531 973 people.13 One study included 
people with type 1 diabetes only,24 two studies included 
people with type 2 diabetes only,23 25 two studies included 
people with both type 1 and type 2 diabetes,26 28 and two 
studies did not report the type of diabetes.13 27 The expo-
sure depression was diagnosed using a validated tool or 
measure in all seven studies. One study23 used the Center 
for Epidemiologic Studies Depression scale and the 
Composite International Diagnostic Interview tools, one 
study24 used the Beck Depression Inventory—version two 
tool, one study28 used the Schedules for Clinical Assess-
ment in Neuropsychiatry tool, two studies25 26 used the 
Patient Health Questionnaire—version 9 tool and two 
studies13 27 used the ICD (International Classification of 
Diseases) codes. The outcome of LEA was self-reported 
in two studies,23 24 medical records were examined in two 
studies,25 26 ICD codes from large database registries were 
used in two studies13 27 and one study used a trained podi-
atrist to diagnose the outcome.28
meta-analysis
Of the seven studies included in the systematic review, 
five13 23 25 27 28 provided sufficient data to be included in 
a meta-analysis. Data on 767 997 patients were included 
in the meta-analysis using the generic inverse variance 
method and reporting the log (HR) and SE for each study. 
In the fixed-effect model, an overall pooled estimate HR 
of 1.21 (95% CI 1.11 to 1.31) was found, implying a 21% 
increased hazard of LEA in people with diabetes and 
depression. Due to the evidence of substantial heteroge-
neity in the fixed-effect model (I2=87%, p≤0.00001), the 
random-effects model was deemed more appropriate. 
The pooled HR of risk of LEA due to depression was 1.76 
(95% CI 1.19 to 2.60) (figure 2).
Significant heterogeneity remained, however (I2=87%, 
p=0.005).
subgroup analyses
It was not possible to conduct a subgroup analysis based 
on type of diabetes as these data were not reported in 
the studies. In addition, we did not conduct a subgroup 
analysis by study design as all five studies were prospective 
cohorts. A subgroup analysis by sample size was conducted 
(figure 3). The overall pooled estimate for studies with a 
sample size <10 000 was 1.55 (95% CI 0.98 to 2.45, I2=44%, 
p=0.17) compared with studies with a sample size >10 000 
for which the pooled estimate was 2.16 (95% CI 0.57 to 
8.23, I2=96%, p≤0.00001). Neither was statistically signif-
icant, however. A subgroup analysis according to where 
the studies were conducted was also performed (figure 4). 
Studies that were conducted in the USA had a pooled HR 
of 1.28 (95% CI 0.99 to 1.66, I2=72%, p=0.03) compared 
with studies conducted in Europe, which had a pooled HR 
of 2.51 (95% CI 0.81 to 7.80, I2=0.009). A subgroup analysis 
according to study quality was also conducted (figure 5). 
Studies with a minimal risk of bias had a pooled HR of 1.34 
(95% CI 1.11 to 1.62, I2=0%, p=0.94). Studies with a low 
risk of bias had a pooled HR of 1.95 (95% CI 0.51 to 7.40, 
I2=79%, p=0.03). One study had a moderate risk of bias 
and a HR of 4.39 (95% CI 2.58 to 7.47). We conducted a 
sensitivity analysis where two studies included the outcome 
LEA as a combined outcome with other microvascular 
complications (figure 6). This yielded a pooled HR of 1.86 
(95% CI 0.78 to 4.48, I2=92%, p=0.00001).
studies not eligible for inclusion in the meta-analysis
Two studies24 26 were not eligible for inclusion in the 
meta-analysis as they did not provide adjusted estimates. 
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Figure 1 Flow diagram outlining the selection of studies for inclusion in the systematic review. PRISMA, preferred reporting 
items for systematic reviews and meta-analyses.
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The main findings and conclusions of these studies 
are presented in table 2. Both were small studies (one 
with 458 participants with diabetes, the second with 54 
participants with diabetes), which only provided crude 
estimates.
Quality assessment
Two studies were assessed as having a minimal risk of 
bias,25 28 two were deemed to have a low risk of bias13 23 
and three had a moderate risk of bias.24 26 27 No study was 
classified as having a high risk of bias (table 3).
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Figure 2 Random-effects model of the risk of lower extremity amputation in people with diabetes associated with 
depression compared with no depression from five published studies (IV=Inverse Variance).
Figure 3 Subgroup analysis: random-effects model of the risk of lower extremity amputation in people with diabetes 
associated with depression compared with no depression according to sample size (<10 000, >10 000) [IV=Inverse Variance].
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dIsCussIOn
Overall, in this pooled analysis, people with diabetes and 
depression had a 76% increased risk of LEA compared 
with people with diabetes without depression; this result 
was statistically significant. There was, however, a high 
level of heterogeneity between studies (I2=87%). To 
investigate this further, we conducted various subgroup 
analyses. Sample size did not explain our findings 
(with large and small studies both showing increased 
but insignificant findings) or the heterogeneity. 
Geographical variation in LEA rates has been previously 
documented.29 30 Potential reasons why results might 
differ between continents would include different popu-
lation characteristics and healthcare systems.31 In this 
review, the region in which the studies were conducted 
(USA vs Europe) also yielded increased but insignificant 
results, and heterogeneity remained. The subgroup anal-
ysis by study quality showed that the studies with the least 
bias (minimal bias) produced a 34% increased risk of 
LEA in people with diabetes and depression, which was 
statistically significant.
While the outcome of interest was LEA, two of the 
included studies (Black et al and Lin et al) grouped the 
outcome of LEA with other microvascular outcomes. It 
was decided to include these studies due to the dearth 
of research in this area and to perform a sensitivity anal-
ysis removing studies that included LEA as a combined 
outcome under ‘microvascular complications’. This anal-
ysis produced an increased but insignificant result.
It must be acknowledged that only five studies were 
eligible for inclusion in the meta-analysis, and this limits 
the robustness of the subgroup analyses performed. 
Thus, while there is an overall increased risk of LEA in 
people with depression and diabetes, further research 
is needed including population-based registry data and 
more methodologically robust methods of recording 
depression, diabetes and LEA (ie, ICD codes or medical 
diagnoses).
group.bmj.com on October 3, 2017 - Published by http://drc.bmj.com/Downloaded from 
7BMJ Open Diab Res Care 2017;5:e000366. doi:10.1136/bmjdrc-2016-000366
Figure 4 Subgroup analysis: random-effects model of the risk of lower extremity amputation in people with diabetes 
associated with depression compared with no depression according to region (USA vs Europe) [IV=Inverse Variance].
Figure 5 Subgroup analysis: random-effects model of the risk of lower extremity amputation in people with diabetes 
associated with depression compared with no depression according to study quality (minimal vs low vs moderate risk of 
bias) [IV=Inverse Variance].
Clinical care/Education/Nutrition/Psychosocial research
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Figure 6 Sensitivity analysis: random-effects model of the risk of lower extremity amputation (LEA) in people with diabetes 
associated with depression compared with no depression where two studies were excluded (LEA was included in these 
studies as a combined outcome ‘microvascular complications’) (IV=Inverse Variance).
Table 2 Results and conclusions of studies not eligible for inclusion in the meta-analysis
Study Results Conclusions
Gendelman et al24 6/458 diabetic participants in the study 
had amputations. No results were provided 
for diabetics who were depressed and not 
depressed in terms of the outcome.
The study authors concluded that ‘Type 1 diabetic 
participants reporting the prevalence of at least 
one diabetic complication scored higher on the 
BDI-II depression scale than participants without 
complications’.
Pearson et al26 2/26 diabetic patients with no depression had 
an amputation compared with 3/28 diabetic 
patients with depression.
Data were missing for six participants (three had 
died, three were lost to follow-up). ‘There was no 
significant difference between the two groups in 
terms of outcome’.
BSI-II, Beck Depression Inventory—version two.
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strengths and limitations of this review
This is the first systematic review that the authors are 
aware of that investigates the association of depression 
with LEA in people with diabetes. A comprehensive 
and systematic literature search examined six data-
bases, yielding seven studies eligible for inclusion in 
the systematic review. Although a significant amount 
of heterogeneity was found between studies in the 
meta-analysis, this was examined using appropriate 
statistical measures as well as a priori defined subgroup 
analyses. The meta-analysis only included studies that 
reported adjusted estimates, as these would be consid-
ered less biased/confounded results, in order to more 
accurately represent the true effect of depression and 
risk of LEA.
The systematic review and meta-analysis is not without 
limitations, however. Caution needs to be applied when 
interpreting the results of the studies on depression 
prevalence as many included poor methodological 
practices such as small sample size and no confirmation 
of difference between type 1 and type 2 diabetes, and 
therefore a subgroup analysis by type of diabetes was not 
possible. There are fundamental differences between 
the conditions in relation to mean age of onset and the 
temporal relationship that could be explored in later 
systematic reviews as additional studies are conducted. 
In addition, all of the studies were conducted in 
high-income, developed countries such as the USA, UK 
and Australia, the results of which would not be gener-
alisable to resource-poor settings. Differences in diet, 
lifestyle and culture between these countries may also 
play a role in diabetes care and thus impact the find-
ings. One study included male war veterans only, and 
these findings would be very specific to this population. 
There was also significant variation in the number of 
potential confounders adjusted that may influence the 
plausibility of the different study findings.
The diagnosis of depression varied according to study 
and included different scales, self-reported diagnosis 
and ICD-9 classifications of depression. Self-reported 
depression is not a reliable method for obtaining true 
prevalence of this disorder, particularly among men. This 
could result in either an overestimate or underestimate of 
the association with LEA. Variability in the exposure defi-
nition may explain the heterogeneity in the meta-analysis
Also, depression status may change over time and 
measurement at one time point only in these studies 
is a limitation. As is a problem with most observational 
studies, unmeasured confounding cannot be ruled out.
Of note, Salmi et al reported on 229 956 patients from 
a national register-based cohort in Sweden, but only an 
abstract for this work was available. The abstract does 
not provide detailed information on the definition of 
depression and LEA, and efforts to contact the authors 
for clarity proved futile. We have inferred the diagnoses 
were made using ICD-9 codes (as this is the method used 
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Table 3 Quality assessment of studies included in the systematic review
Study
Selection 
bias
Exposure 
bias
Outcome 
assessment 
bias
Confounding 
factor bias
Analytical 
bias
Attrition 
bias
Overall 
likelihood of 
bias
Black et al23 Low Minimal Minimal Low Minimal Moderate Low
Gendelman et al24 Moderate Minimal Minimal Moderate Moderate Low Moderate
Lin et al25 Minimal Minimal Minimal Minimal Minimal Low Minimal
Pearson et al26 Low Low Minimal Moderate Moderate Moderate Moderate
Salmi et al27 Minimal Low Low Not reported Not reported Minimal Moderate
Williams et al13 Low Low Low Minimal Low Low Low
Winkley et al28 Low Minimal Minimal Minimal Low Minimal Minimal
The six different types of bias were classified as ‘minimal’, ‘low’, ‘moderate’, ‘high’ or ‘not reported’ based on criteria outlined previously in 
O’Neill et al.22
Clinical care/Education/Nutrition/Psychosocial research
generally in previous research using the Swedish national 
data). This is an acknowledged limitation of the review, 
however.
Heterogeneity
There was a great degree of heterogeneity in the current 
meta-analysis and would be deemed ‘high’ according to 
the Cochrane criteria for I2 (>75%).21 The authors tried 
to control for this heterogeneity by using the random-ef-
fects model. Under the random-effects model, we allow 
that the true effect could vary from study to study. For 
example, the effect size might be a little higher if the 
subjects are older, or more educated, or healthier; or if 
the study used a slightly more intensive or longer variant 
of the intervention; or if the effect was measured more 
reliably. In addition, we quantified heterogeneity by 
using the I2 statistic that focuses attention on the effect of 
any heterogeneity in the meta-analysis, the percentage of 
total variation across studies is due to heterogeneity and 
most importantly in the case of the current meta-analysis, 
the I2 value does not depend on the number of studies 
in the meta-analysis.18 Ideally, to further explore reasons 
for heterogeneity, authors would conduct a priori defined 
subgroup and sensitivity analyses as well as meta-re-
gression using different covariates. These are largely 
dependent on the number of studies in the meta-analysis, 
however, and were not feasible for the current meta-anal-
ysis.
Recommendations for future research
Differing definitions and assessment tools for diagnosing 
depression were used in the studies included in this 
systematic review. The reported prevalence of depres-
sion differs between self-report versus clinical interview 
diagnosis.32 The use of a standard assessment tool for 
depression would improve comparability of results from 
different settings. Further research is required to explore 
whether the level of severity of depression is predic-
tive of complications. Potential confounders needing 
consideration in future research include age, gender, 
education, marital status/living alone, socioeconomic 
status, type of diabetes, duration of diabetes, insulin 
use,diabetes treatment/control, self-reported health 
status, risk behaviours, quality of life, foot care behavior, 
mood, smoking status, alcohol problems, macrovascular 
complications, microvascular complications, foot-specific 
complications, severity of complications, other medical 
or mental health conditions, and healthcare utilisation.
The literature review confirmed clinical practices vary 
per individual practitioner, per location and per patient.3 
The evidence of under-diagnosing depression in patients 
with diabetes needs to be considered as a potential bias. 
Such bias would cause over-reporting of LEAs in patients 
with no comorbidity and under-reporting of LEAs in 
patients with comorbid depression.
COnClusIOns
In conclusion, there appears to be an unfavorable effect 
of comorbid depression in people with diabetes on the 
risk of LEA. Given the significant heterogeneity present 
between studies and the need for studies of a more robust 
methodological quality, the current findings need to be 
interpreted with caution. To detect the true effect, future 
longitudinal studies need to include large sample sizes 
with a breakdown by type of diabetes, assess confounders 
at baseline and follow-up and adjust for confounders in the 
statistical analysis. Further research is needed to explore 
the role of comorbid depression as a risk factor for LEA, 
to document the effect size and, thus, to inform interven-
tion and clinical practice development. Considering the 
availability of various treatments for depression,33 efforts 
to detect the true effect of comorbid depression on the 
risk of LEA and indeed other complications in people 
with diabetes are worthwhile.
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